Once an exciting but niche technology, DIA mass spectrometry has transformed proteomics. In his new article, Biognosys' CTO, Lukas Reiter, takes us through the journey to this poin [...]Read more
Immunopeptidome profiling at this scale provides a detailed snapshot of what the immune system reacts to within a particular tissue. This has important implications for understandi [...]Read more
Mass spectrometry-based structural proteomics provides deep insights into drug-protein interactions for drug target identification and validation to de-risk your drug development p [...]Read more
As we opened our first US office, Biognosys is looking back and looking ahead: what changed in Mass Spectrometry-based proteomics, and how are we shaping this powerful technology? [...]Read more
Proteomics is relevant not only to human health and disease, but also to animal species. In an exciting collaboration with the Leibniz Institute for Zoo and Wildlife Research (IZW) [...]Read more
What is the future of diagnostics? The past 20 years have seen the rise of #genomics, but according to Deloitte, we are now in the decade of proteomics, enabling a more revolutiona [...]Read more
Access our knowledge base with relevant resources and guiding information.